EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
We are looking for a new Chemistry curator to join the ChEBI team. Find out more about it here.
CHEBI:231681 - olaratumab
| ChEBI ID | CHEBI:231681 |
| ChEBI Name | olaratumab |
| Stars | |
| Definition | Olaratumab is a platelet-derived growth factor receptor alpha blocking antibody used with doxorubicin to treat patients with certain types of soft tissue sarcoma (STS). (DrugBank) |
| Submitter | amillett1 |
| Roles Classification |
|---|
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| olaratumab (CHEBI:231681) has role antineoplastic agent (CHEBI:35610) |
| olaratumab (CHEBI:231681) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| IMC-3G3 | SUBMITTER |
| IMC3G3 | ChEMBL |
| Olaratumab | ChEMBL |
| Brand Name | Source |
|---|---|
| Lartruvo | ChEMBL |